Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 913-924 of 4,306
Drug study icon
CompletedNCT03359785

Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia

This study is completed in the United States. It is testing multiple Oral Doses of Luvadaxistat for schizophrenia.

In Gaithersburg
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
United States
Sponsor
Neurocrine Biosciences
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05686239

RL-007 for schizophrenia

This study is completed in the United States, in Bulgaria, in Czechia, .... It is testing RL-007 for schizophrenia.

Multiple locations, including Culver City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
United States, Bulgaria, Czechia, ...
Sponsor
Recognify Life Sciences
Condition
Schizophrenia
Drug study icon
TerminatedNCT05443724

Safety study of CVL-231 (Emraclidine) in schizophrenia

This study was terminated in the United States, in Bulgaria, in Hungary, .... It is testing CVL-231 (Emraclidine) for schizophrenia.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States, Bulgaria, Hungary, ...
Sponsor
AbbVie
Condition
Schizophrenia
Drug study icon
CompletedNCT05893862

Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia

This study is completed in the United States. It is testing Effect Of A Supratherapeutic Dose Of Elpipodect On The QTc Interval for schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Merck Sharp & Dohme LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT01527305

Effectiveness of effectiveness and Safety of Paliperidone Palmitate in schizophrenia

This study is completed in China, in Malaysia, in South Korea, .... It is testing effectiveness and Safety of Paliperidone Palmitate for schizophrenia.

Multiple locations, including Huzhou
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
China, Malaysia, South Korea, ...
Sponsor
Janssen Research & Development, LLC
Condition
Schizophrenia
Drug study icon
CompletedNCT02969382

SEP-363856 for schizophrenia

This study is completed in the United States, in Hungary, in Romania, .... It is testing SEP-363856 for schizophrenia.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 40 Years
Countries
United States, Hungary, Romania, ...
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06136936

Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia

This study is completed in the United States. It is testing Overall Effects of Treatment With Abbreviated CT-156 for schizophrenia.

In New York
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralOver 18 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT03745820

Safety study of Safety and Efficacy of BIIB104 in schizophrenia

This study is completed in the United States, in the United Kingdom, in Germany, .... It is testing Safety and Efficacy of BIIB104 for schizophrenia.

Multiple locations, including Bentonville
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States, United Kingdom, Germany, ...
Sponsor
Biogen
Condition
Schizophrenia
Drug study icon
CompletedNCT06107803

Safety study of Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine in schizophrenia

This study is completed in the United States. It is testing Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of Co-Administration of Roluperidone and Olanzapine for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 55 Years
Countries
United States
Sponsor
Minerva Neurosciences
Condition
Schizophrenia
Drug study icon
CompletedNCT03893825

A Study to Test if TV-46000 is Safe for Maintenance Treatment of Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Phoenix
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 13 Years to 65 Years
Countries
United States, France, Canada, ...
Sponsor
Teva Branded Pharmaceutical Products R&D, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT02282761

A study to Assess the Antipsychotic Efficacy of ITI-007

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Little Rock
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
Intra-Cellular Therapies, Inc.
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.